GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Gross Profit

Cognetivity Neurosciences (XCNQ:CGN) Gross Profit : C$0.10 Mil (TTM As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Gross Profit?

Cognetivity Neurosciences's gross profit for the three months ended in Oct. 2023 was C$0.03 Mil. Cognetivity Neurosciences's gross profit for the trailing twelve months (TTM) ended in Oct. 2023 was C$0.10 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Cognetivity Neurosciences's gross profit for the three months ended in Oct. 2023 was C$0.03 Mil. Cognetivity Neurosciences's Revenue for the three months ended in Oct. 2023 was C$0.03 Mil. Therefore, Cognetivity Neurosciences's Gross Margin % for the quarter that ended in Oct. 2023 was N/A%.

Cognetivity Neurosciences had a gross margin of N/A% for the quarter that ended in Oct. 2023 => No sustainable competitive advantage


Cognetivity Neurosciences Gross Profit Historical Data

The historical data trend for Cognetivity Neurosciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Gross Profit Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Gross Profit
Get a 7-Day Free Trial - - - - 0.05

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.05 - 0.02 0.03

Competitive Comparison of Cognetivity Neurosciences's Gross Profit

For the Health Information Services subindustry, Cognetivity Neurosciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Gross Profit falls into.



Cognetivity Neurosciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cognetivity Neurosciences's Gross Profit for the fiscal year that ended in Jan. 2023 is calculated as

Gross Profit (A: Jan. 2023 )=Revenue - Cost of Goods Sold
=0.045 - 0
=0.05

Cognetivity Neurosciences's Gross Profit for the quarter that ended in Oct. 2023 is calculated as

Gross Profit (Q: Oct. 2023 )=Revenue - Cost of Goods Sold
=0.029 - 0
=0.03

Gross Profit for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.10 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Cognetivity Neurosciences's Gross Margin % for the quarter that ended in Oct. 2023 is calculated as

Gross Margin % (Q: Oct. 2023 )=Gross Profit (Q: Oct. 2023 ) / Revenue (Q: Oct. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.03 / 0.029
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cognetivity Neurosciences  (XCNQ:CGN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cognetivity Neurosciences had a gross margin of N/A% for the quarter that ended in Oct. 2023 => No sustainable competitive advantage


Cognetivity Neurosciences Gross Profit Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (XCNQ:CGN) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.
Executives
Ravinder Kang Director

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines